OptimizeRx (OPRX) Non-Current Deferred Tax Liability (2018 - 2026)

OptimizeRx's Non-Current Deferred Tax Liability history runs 9 years deep, the most recent figure standing at $5.7 million for Q1 2026.

• In Q1 2026, Non-Current Deferred Tax Liability rose 49.37% year-over-year to $5.7 million; the TTM figure through Mar 2026 stood at $5.7 million (up 49.37% YoY), while the FY2025 annual figure was $5.7 million, up 27.03% from the prior year.
• Non-Current Deferred Tax Liability came in at $5.7 million for Q1 2026 at OptimizeRx, down from $5.7 million in the prior quarter.
• In the past five years, Non-Current Deferred Tax Liability ranged from a high of $5.7 million in Q4 2025 to a low of $2.3 million in Q4 2022.
• A 5-year average of $4.1 million and a median of $4.3 million in 2023 frame the typical range for Non-Current Deferred Tax Liability.
• Across the five-year window, Non-Current Deferred Tax Liability jumped 86.14% in 2023 and dropped 20.27% in 2025, its largest moves.
• OptimizeRx's Non-Current Deferred Tax Liability stood at $2.3 million in 2022, then surged by 86.14% to $4.3 million in 2023, then gained by 3.55% to $4.5 million in 2024, then increased by 27.03% to $5.7 million in 2025, then dropped by 0.88% to $5.7 million in 2026.
• According to Business Quant data, Non-Current Deferred Tax Liability over the past three periods registered $5.7 million, $5.7 million, and $4.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison